Oasmia Pharmaceutical AB : Prospectus regarding Oasmia Pharmaceutical’s rights issue is now available

The Board of Directors of Oasmia Pharmaceutical AB (publ) (“Oasmia”) has prepared a prospectus for the purpose of the rights issue, which was announced on October 18, 2012. The prospectus has today been approved by and registered with the Swedish Financial …

Share